These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2273258)
21. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system. Williams RC; Malone CC; Huffman GR; Silvestris F; Croker BP; Ayoub EM; Massengill S J Rheumatol; 1995 Jun; 22(6):1075-85. PubMed ID: 7674233 [TBL] [Abstract][Full Text] [Related]
22. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system. Antes U; Heinz HP; Loos M J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573 [TBL] [Abstract][Full Text] [Related]
23. A C1Q enzyme-linked immunosorbent assay (ELISA) using polyethylene glycol for immune complexes. Lunde MN Am J Trop Med Hyg; 1983 Mar; 32(2):392-6. PubMed ID: 6340543 [TBL] [Abstract][Full Text] [Related]
24. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases]. Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907 [TBL] [Abstract][Full Text] [Related]
25. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera. Shrier DA; Taniguchi O; Barnett EV J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052 [TBL] [Abstract][Full Text] [Related]
26. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC). Harkiss GD; Brown DL Clin Exp Immunol; 1979 Apr; 36(1):117-29. PubMed ID: 111880 [TBL] [Abstract][Full Text] [Related]
27. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422 [TBL] [Abstract][Full Text] [Related]
28. Analysis of polyethylene glycol precipitates from SLE sera: antibody enrichment in association with disease activity. Skinner RP; Maddison PJ Clin Exp Rheumatol; 1990; 8(6):553-60. PubMed ID: 1705188 [TBL] [Abstract][Full Text] [Related]
29. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes. Valentijn RM; van Es LA; Daha MR J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050 [TBL] [Abstract][Full Text] [Related]
30. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. Digeon M; Laver M; Riza J; Bach JF J Immunol Methods; 1977; 16(2):165-83. PubMed ID: 881555 [TBL] [Abstract][Full Text] [Related]
31. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583 [TBL] [Abstract][Full Text] [Related]
32. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA. Stanilova SA; Slavov ES J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665 [TBL] [Abstract][Full Text] [Related]
33. Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus. Silvestris F; Searles RP; Bankhurst AD; Williams RC Clin Exp Immunol; 1985 May; 60(2):329-38. PubMed ID: 3874025 [TBL] [Abstract][Full Text] [Related]
34. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis. Sølling J; Sølling K; Jacobsen KU Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365 [TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes in nephritis. Coppo R; De Marchi M; Segoloni G; Quarello F; Piccoli G Ric Clin Lab; 1977; 7(4):354-64. PubMed ID: 353960 [TBL] [Abstract][Full Text] [Related]
36. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms. Iida K; Mitomo K; Fujita T; Tamura N J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809 [TBL] [Abstract][Full Text] [Related]
37. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; Vanes LA Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604 [TBL] [Abstract][Full Text] [Related]
38. Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis. Nilsson B; Bjelle A; Lööf L; Nilsson UR J Clin Immunol; 1987 Sep; 7(5):420-6. PubMed ID: 2443529 [TBL] [Abstract][Full Text] [Related]
39. [Detection of circulating immune complexes by three techniques using polyethylene glycol (author's transl)]. Digeon M; Bach JF Nouv Presse Med; 1977 Dec; 6(43):4031-7. PubMed ID: 600749 [TBL] [Abstract][Full Text] [Related]
40. [Demonstration and differentiation of circulating immune complexes in chronic inflammatory rheumatic diseases using a semiautomated PEG-precipitation laser nephelometer test]. Geissler N; Kemper A; Krapf E; Renger D; Schedel I; Deicher H Z Rheumatol; 1985; 44(2):57-63. PubMed ID: 4050141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]